相似文献
1
Heart failure in elderly patients: distinctive features and unresolved issues.
Eur J Heart Fail. 2013 Jul;15(7):717-23. doi: 10.1093/eurjhf/hft028. Epub 2013 Feb 20.
2
Aging and heart failure: changing demographics and implications for therapy in the elderly.
Heart Fail Rev. 2010 Sep;15(5):401-5. doi: 10.1007/s10741-010-9164-8.
3
Current Prevalence, Incidence, and Outcomes of Heart Failure with Preserved Ejection Fraction.
Heart Fail Clin. 2021 Jul;17(3):315-326. doi: 10.1016/j.hfc.2021.03.002.
4
[Chronic heart failure].
Cas Lek Cesk. 2015;154(6):260-8.
5
Transition of Left Ventricular Ejection Fraction in Heart Failure.
Adv Exp Med Biol. 2018;1067:5-15. doi: 10.1007/5584_2018_178.
6
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction.
J Am Coll Cardiol. 2019 Aug 6;74(5):601-612. doi: 10.1016/j.jacc.2019.05.052.
7
STEMI and heart failure in the elderly: role of adverse remodeling.
Heart Fail Rev. 2010 Sep;15(5):513-21. doi: 10.1007/s10741-010-9177-3.
8
Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions.
Cardiol Clin. 2019 May;37(2):131-138. doi: 10.1016/j.ccl.2019.01.002. Epub 2019 Feb 20.
9
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
JACC Heart Fail. 2019 Apr;7(4):306-317. doi: 10.1016/j.jchf.2018.11.019. Epub 2019 Mar 6.
10
Coexisting Morbidities in Heart Failure: No Robust Interaction with the Left Ventricular Ejection Fraction.
Curr Heart Fail Rep. 2020 Aug;17(4):133-144. doi: 10.1007/s11897-020-00461-3.
引用本文的文献
1
Burden and etiology of heart failure in mainland China from 1990 to 2021: Results from the GBD 2021 study.
Int J Cardiol Cardiovasc Risk Prev. 2025 Aug 22;27:200497. doi: 10.1016/j.ijcrp.2025.200497. eCollection 2025 Dec.
2
Enhanced Multi-Model Machine Learning-Based Dementia Detection Using a Data Enrichment Framework: Leveraging the Blessing of Dimensionality.
Bioengineering (Basel). 2025 May 30;12(6):592. doi: 10.3390/bioengineering12060592.
3
Albumin-Bilirubin (ALBI) Score Predicts Long-Term Survival in Elderly Patients with Decompensated Heart Failure.
J Clin Med. 2025 Jan 26;14(3):808. doi: 10.3390/jcm14030808.
4
Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF.
Circ Heart Fail. 2024 Nov;17(11):e012437. doi: 10.1161/CIRCHEARTFAILURE.124.012437. Epub 2024 Sep 29.
5
Age-Related Outcomes in Heart Failure with Mildly Reduced Ejection Fraction.
J Clin Med. 2024 Aug 30;13(17):5151. doi: 10.3390/jcm13175151.
6
Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement.
JACC Adv. 2024 Aug 16;3(9):101212. doi: 10.1016/j.jacadv.2024.101212. eCollection 2024 Sep.
7
Effect of SGLT-2 inhibitors on acute kidney injury in patients with heart failure: a systematic review and meta-analysis.
Diabetol Metab Syndr. 2024 Aug 27;16(1):207. doi: 10.1186/s13098-024-01446-1.
8
Prevalence of heart failure and trends in its pharmacological treatment between 2000 and 2017 among very old people.
BMC Geriatr. 2024 Aug 24;24(1):701. doi: 10.1186/s12877-024-05307-4.
9
Global trends in heart failure from 1990 to 2019: An age-period-cohort analysis from the Global Burden of Disease study.
ESC Heart Fail. 2024 Oct;11(5):3264-3278. doi: 10.1002/ehf2.14915. Epub 2024 Jun 27.
10
Effects of renin-angiotensin system inhibitor and beta-blocker use on mortality in older patients with heart failure with reduced ejection fraction in Japan.
Front Cardiovasc Med. 2024 May 31;11:1377228. doi: 10.3389/fcvm.2024.1377228. eCollection 2024.
本文引用的文献
1
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
Eur J Heart Fail. 2012 Aug;14(8):803-69. doi: 10.1093/eurjhf/hfs105.
2
Diagnosis of elderly patients with heart failure.
Eur J Heart Fail. 2012 Oct;14(10):1097-103. doi: 10.1093/eurjhf/hfs109. Epub 2012 Jul 6.
3
Applicability of a risk score for prediction of the long-term (8-year) benefit of the implantable cardioverter-defibrillator.
J Am Coll Cardiol. 2012 Jun 5;59(23):2075-9. doi: 10.1016/j.jacc.2012.02.036.
4
Comparison of processes of care and clinical outcomes for patients newly hospitalized for heart failure attended by different physician specialists.
Am Heart J. 2012 Feb;163(2):252-9. doi: 10.1016/j.ahj.2011.11.012.
5
Prevention of heart failure in the elderly: when, where and how to begin?
Heart Fail Rev. 2012 Sep;17(4-5):531-44. doi: 10.1007/s10741-012-9299-x.
6
Congestive heart failure in the elderly: comparison between reduced ejection fraction and preserved ejection fraction.
J Cardiol. 2012 Mar;59(2):215-9. doi: 10.1016/j.jjcc.2011.11.014. Epub 2012 Jan 21.
7
Mechanical circulatory support for elderly heart failure patients.
Heart Fail Rev. 2012 Sep;17(4-5):663-9. doi: 10.1007/s10741-012-9298-y.
8
Comorbidity drives mortality in newly diagnosed heart failure: a study among geriatric outpatients.
J Card Fail. 2012 Jan;18(1):47-52. doi: 10.1016/j.cardfail.2011.10.009. Epub 2011 Nov 25.
9
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.
Circulation. 2012 Jan 3;125(1):e2-e220. doi: 10.1161/CIR.0b013e31823ac046. Epub 2011 Dec 15.
10
Heart failure with preserved ejection fraction.
Circulation. 2011 Nov 22;124(21):e540-3. doi: 10.1161/CIRCULATIONAHA.111.071696.
Zotero 插件